Talk:Vasopressin

Move (2005)
I feel like this article should be moved to Vasopressin. First of all, it would allow us to quickly get out of the way the issue of arginine vasopressin vs. lysine vasopressin. More importantly, the actions of vasopressin go way beyond water retention, etc.. ADH is a pretty outdated name. AVP has a lot of important neuralpeptide actions, as a social recognition signal in the forebrain. Hard to get into this in the current article structure and with the current title. --Chinasaur 19:14, 28 Jan 2005 (UTC)


 * Vasopressin is probably a good title, and is increasingly being used instead of ADH. It is, incidentally, still not indicative of its function outside the vascular and renal signal transduction systems. Could you please add more about the social recognition signal role? I know nothing about this! JFW | T@lk  02:12, 30 Jan 2005 (UTC)

Just a note from a google searcher... Both articles (ADH and Vasopressin) are practically the same, and neither mentions VP's effect on urea reabsorption, which is a fairly important effect.


 * The articles are identical: vasopressin redirects here. Why is urea reabsorption so important in this article? JFW | T@lk  15:39, 25 January 2006 (UTC)


 * ADH's effect on urine concentration isn't only due to its effects on water permeability; a large part of this effect is from ADH's contribution to the osmolality of the medullary interstitium, which is where urea is of great importance. ADH acts on the inner medullary collecting tubules, raising their permeability to urea and allowing its reabsorption. This raises the interstitial osmolality substantially (by as much as 500-600 mOsm/kg), which &mdash; combined with the increased collecting duct water permeability &mdash; drives the reabsorption of water from the collecting duct, leading to highly concentrated urine. --David Iberri (talk) 03:47, 15 March 2006 (UTC)

Official name of vasopressin
I was recently taught that ADH is the better name, and that vasopressin is outdated - higher quantities are needed for ADH to act as vasopressin, and its primary function is as an anti-diuretic hormone - ie, it stops diuresis. Also, there is still no mention of urea in the article - I don't feel qualified to put this in, but it does seem like rather a large omission. 131.111.8.104 11:19, 16 May 2007 (UTC)


 * AVP is the official name agreed upon by the international naming association. Also, probably very few named substances are limited to what their name implies. AVP, for example, has many roles in the brain regulating various behaviors that are important for understanding human social interactions. AlbertHall 13:58, 16 May 2007 (UTC)


 * The approved gene symbol and name is arginine vasopressin (see |ref).

Infobox error
There is an error in the second infobox, but I haven't a clue how to fix those prot box things. Fuzzform 20:08, 11 February 2006 (UTC)


 * What's the error? AxelBoldt 01:49, 12 February 2006 (UTC)

Some references to all the various effects of vasopressin would be nice...


 * Vasopressin is secreted from parvocellular neurons

Should "parvocellular" be linked to parvocellular part or is this a different use of the term? AxelBoldt 15:27, 6 April 2006 (UTC)


 * The terms refer to different things. That article refers to part of the lateral geniculate nucleus, which is involved in the visual system. In the context of AVP, parvocellular refers to cells of the paraventricular nucleus. So no linkage necessary. --David Iberri (talk) 18:03, 6 April 2006 (UTC)

DDAVP induced VWF release goes through the vasopressin-2 receptor. This is a cAMP-mediated process. Prayingmantis78 18:58, 4 June 2007 (UTC)

Dosages for asystolic arrest?
I would like to see the vasopressin dosages typically used in asystolic arrest posted. 75.19.187.142 18:40, 1 April 2007 (UTC)Yaek
 * The 2005 AHA guidelines note one 40 U dose of vasopressin may be used in lieu of epinephrine in "all pulseless cardiac arrest scenarios", including asystole. On a side note, WP:MEDMOS discourages the addition of dosing information to articles. Fvasconcellos 18:50, 1 April 2007 (UTC)

caffeine and vasopressin- Reference?
Caffeine is certainly a diuretic and natriuretic, but I can't find any original research article saying caffeine decreases vasopressin release. I found one saying it may be having its effect via adenosine receptors. Timo Rieg, Hannah Steigele, Jurgen Schnermann, Kerstin Richter, Hartmut Osswald, and Volker Vallon. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther. 2005 Apr;313(1):403-9. Epub 2004 Dec 8. Misskidney 19:49, 16 April 2007 (UTC)


 * I was just here to say the same thing. Indeed the diuretic article lists caffiene as a sodium reabsorption inhibitor and not as a vasopressin inhibitor. Potkettle 12:05, 30 July 2007 (UTC)

ADH is definitely a more appropriate name
The name vasopressin is indeed outdated, all newer textbooks I've seen use ADH. Vasoconstriction is only a tertiary fuction of this hormone expressed in the extreme case of hemorrage. Its main function is homeostasis as antidiuretic hormone therefore ADH is definitely a more appropriate name. EerieNight 11:02, 25 August 2007 (UTC)


 * You may believe that vasopressin is outdated, but that train has left the station. The international nomenclature commission has assigned vasopressn and AVP as the official name and symbol, respectively, for the gene and peptide. And, although ADH describes its action at the kidney, it fails as much as AVP does to describe the equally important actions of vasopressin at the pituitary and within the brain.AlbertHall 16:52, 25 August 2007 (UTC)

I concur that arginine vasopressin (AVP) is the more appropriate name to use. And just the opposite, the use of ADH is antiquated. A simple pubmed search will reveal that the vast majority of research articles refer to this hormone as arginine vasopressin (AVP). In addition, the gene name is arginine vasopressin (NM_000490.4) and the names of the receptor are arginine vasopressin receptors, i.e., AVPR1a, AVPR1b, and AVPR2. — Preceding unsigned comment added by 71.185.67.31 (talk) 21:54, 25 November 2013 (UTC)

WikiProject class rating
This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:32, 10 November 2007 (UTC)

Aren't there higher levels of vasopressin in males than in females?
Anyone know why this is? 72.161.203.107 (talk) 02:15, 19 November 2007 (UTC)
 * That is true in a few brain areas but if you are talking about total vasopressin in the animal, that contribution is miniscule. AlbertHall (talk) 13:28, 19 November 2007 (UTC)


 * AVP/AVT acts only as ADH when it is secreted into plasma by the hypothalamus. Locally, in different regions of the brain, it acts as a neuromodulator of behavior.  In some regions of the brain, and in some animals, AVT/AVP is higher in males than females.  Still, in other animals (and other regions of the brain), the converse is true.  --Reefpicker (talk) 19:16, 24 April 2009 (UTC)

Apparently vasopressin is linked with agressive behaviour in males and anti-agressive behaviour in females http://www.standaard.be/cnt/dmf20180706_03601976 — Preceding unsigned comment added by Patrick3004 (talk • contribs) 10:20, 7 July 2018 (UTC)

In need of Revision
Under the Kidney Action section. I think the discussion of the G protein-coupled receptor, and cAMP second messenger systems are inappropriate. A description of the V2 receptor as a G protein-coupled receptor acting by a cAMP second messenger system would be a sufficient description. For the interim I have left the section unchanged except for a link to the appropriate article. —Preceding unsigned comment added by Backwardtoes (talk • contribs) 10:14, 15 December 2007 (UTC)

This article should be revised
The section describing the interaction of vasopressin and behavior is, like too much scientific and medical writing, a maddening exercise in circumlocution. For Pete's sake, state what the hormone does or doesn't do and let the article be revised by someone else in the future rather than write an article for the ages so open-ended that it ought not to have been written at all because it says absolutely NOTHING.

The description of G protein signaling by G alpha s within the "Kidney" chapter is a crap.

G protein alpha subunit does exchange GDP by GTP for activation and not - as described here - vice versa.

The cyclisation of ATP to cAMP does not provide 2 anorganic phosphates. Indeed, one molecule of pyrophosphate is produced.

cAMP may regulate the gene repressor of PKA. However, this cellular response would be far to slow. For fast response reactions the interaction of cAMP to regulatory subunits of PKA is important, resulating in the release of PKAs catalytic subunits. —Preceding unsigned comment added by 85.179.128.249 (talk) 15:25, 10 March 2008 (UTC)

ADH and Na retention
To explain a small (but important) edit I made...

Previously, the article stated that ADH retains water, but not salt. This is not entirely true.

ADH's primary function is indeed to increase water permeability in the collecting system. However, ADH also stimulates Na/K/Cl cotransport (in the thick asc. limb of loop of Henle), and stimulates apical Na channels in collecting tubules. Source: Boron & Boulpaep, Medical Physiology, Updated Ed., p. 787.

I have changed the page (removing the words "but not salt").

Enclosed please find a helpful reference for sodium reabsorption by - acute - admionitration of AVP, with serveral further referecnes, which one might use as citation within the article. Chronic administartion of AVP has not been studies so far. AVP has an intrinsic activity on the amiloride-sensitive sodium channel ENaC of the collecting duct of the kidney, and the epithelium of the colon (Bücker 2018), with increased reabsortion of Na. however Na absortion might require highter concentrations of AVP than water reabsorption.

Am Soc Nephrol •	•	•	. 2005 Jul;16(7):1920-8. doi: 10.1681/ASN.2004121079. Epub 2005 May 11. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans Lise Bankir 1, Sandrine Fernandes, Pascale Bardoux, Nadine Bouby, Daniel G Bichet Affiliations expand •	PMID: 15888562 •	DOI: 10.1681/ASN.2004121079Mucosal Immunol . 2018 Mar;11(2):474-485. doi: 10.1038/mi.2017.66. Epub 2017 Aug 2. Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon R Bücker 1, S M Krug 1, V Moos 2, C Bojarski 2, M R Schweiger 3, M Kerick 3, A Fromm 1, S Janßen 2, M Fromm 1, N A Hering 4, B Siegmund 2, T Schneider 2, C Barmeyer 2, J D Schulzke 1 Affiliations expand PMID: 28766554 DOI: 10.1038/mi.2017.66Robertley1 (talk) 10:44, 24 August 2020 (UTC)

---bob (talk) 18:26, 21 March 2008 (UTC)

I have also added the word "main" in the paragraph describing vasopressin's effects in the kidney to clarify that it does play other roles (ie. increase of Na-K-Cl2 channels in the TAL)

--User:Soroboto (talk) 18:13, 18 October 2013 (UTC)

Camels
Do Camels have any sort of increased retention of ADH and that is how they save so much water? 76.14.97.253 (talk) 17:47, 4 April 2008 (UTC)

Vassopressin in septic shock
Vassopressin has been shown to be ineffective in septic shock when added to Norepinephirine, no mortality benefit at 28 days and at 90 days. —Preceding unsigned comment added by Alshamsi2000 (talk • contribs) 02:58, 14 July 2008 (UTC)

preprohormone
This article never actually mentions which preprohormone or whatever you call it vasopressin comes from. It comes from preprooxyphysin, as does Neurophysin I apparently. Same problem with the oxytocin article. —Preceding unsigned comment added by Pelirojopajaro (talk • contribs) 13:52, 9 March 2009 (UTC)


 * Generally, the preprohormone's name is the same as the major hormone. In the cases of vasopressin and oxytocin, they are just the vasopressin preprohormone and oxytocin preprohormone, respectively. Therefore, the article is accurate in just saying that vasopressin comes from a preprohormone. Interestingly, there are only 9 Google hits for the term preprooxyphysin and none for a preprovasophysin. AlbertHall (talk) 15:32, 9 March 2009 (UTC)

Requested move

 * The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section. 

The result of the move request was no consensus for move.   A rbitrarily 0   ( talk ) 22:52, 24 November 2009 (UTC)

Vasopressin → arginine vasopressin — As the preceding explanation by AlbertHall indicates, the official name is arginine vasopressin. I suggest renaming this article as arginine vasopressin and redirecting vasopressin here --Chibibrain (talk) 04:15, 16 November 2009 (UTC)


 * Comment the article mentions that there are non-arginine vasopressins not covered by this article... 76.66.197.2 (talk) 04:45, 16 November 2009 (UTC)
 * There are indeed more than one type of vasopressin. Perhaps most of the material here should be moved to a dedicated article on arginine vasopressin. In this case, this article should provide an overview of each type of vasopressin, such as arginine vasopressin and lysine vasopressin. A dedicated article on arginine vasopressin is justifed because it pertains to human physiology. Whether we rename this article or not, most of the material in the article should be under the official term "arginine vasopressin", but not the common term "vasopressin".--Chibibrain (talk) 06:24, 16 November 2009 (UTC)


 * Disagree with some of the logic here. The common name is in principle preferred to the official name. Andrewa (talk) 02:05, 17 November 2009 (UTC)

In light of the naming convention, I now believe it is better to leave the article name unchanged. Perhaps it is best to just provide a statement near the beginning that there are homologous peptides for other species. In any case, this name change proposal should be rejected due to a lack of consensus.--Chibibrain (talk) 11:11, 17 November 2009 (UTC)
 * Comment making human things primary seems to promote WP:Systematic bias 76.66.197.2 (talk) 04:36, 19 November 2009 (UTC)
 * Comment a dab page is in order in any case, somewhere. 76.66.197.2 (talk) 04:36, 19 November 2009 (UTC)
 * Comment I would like to point out that the vast majority of peer-reviewed, scientific papers discussing vasopressin in mammals (including humans) don't use arginine as a modifier. Vasopressin alone is used. Similarly, scientific meetings have symposia that rarely, if ever, modify vasopressin in their titles. The term vasopressin is really not confusing and is more encompassing (e.g., note the table in the article). AlbertHall (talk) 14:35, 19 November 2009 (UTC)
 * The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.

Peripheral resistance
I realize such assertions seem unwelcome sometimes, but I wish to call attention to a specific lack of rigor with regard to (1) the use of the term peripheral resistance, and (2) the belief that the mammalian arterial pressure is regulated via any mechanism involving the direct control of generalized peripheral resistance. This latter concept reached its heyday forty years ago when Frank Netter illustrated ads for Ciba-Geigy's Apresoline. The simple fact is that the net venous return is a real measurable phenomenon, and peripheral resistance is an artificial concept defined by a word experiment. The net venous return at the heart is the sum of all the local blood flows. Each local blood flow is determined by local arteriolar diameters, which in turn relate to specific local mechanisms — from oxygen tension in many cells to carbon dioxide in others. Also, when autonomic neurohormonal factors override local mechanisms, the various results can include death from shock. Remember, we are talking about Homeostasis, not the Ischemic Reflex. Local arterioles MUST respond to changes in BP in order to provide the correct local flow. Not the other way around. Every physiologist knows this. Since Harvey.

Most engineers would understand how these circulatory systems are easily described as elastic reservoir trees interconnected with programmable peripheral current sources, and a variable transconductance amplifier heart. However, a simple experiment can show it far more easily. My father did this at Emory University School of Medicine in 1945. Some number of subjects are tested on a ballistocardiogram (which estimates cardiac output). Their pressures are measured before and after by cuff. Between measurements, you release a previously attached tourniquet from one or both legs, and the blood rushes in due to reactive hyperemia. This shows a 2X to 5X increase in total blood flow. Yet blood pressures are still well regulated here, showing both small increases and decreases, presumably related to discomfort or fear in the procedure.

Based on my studies at my father knee, and extensive simulations in the Pennsylvania State University Hybrid Computer Lab and the Penn State mainframe (1976), the sensitivities of the mammalian circulation to small changes in "Total Blood Flow" (a proxy for "PR") would never keep pace with the big blood flow changes that are otherwise normal among organs doing their normal jobs. Simulations suggest that short term regulation seems reasonably likely by modifying the heart function (increased contractility and hear rate) and long term arterial blood pressure control is synonomous with body fluid level control, especially the total blood volume. Other mechanisms (rather than direct control of PR) seem likely as well. Arthur Guyton tried to bring this out, but he lacked credibility as a theorist later in his career. Vasodilators, obviously, can have a big impact on blood volume if they act on the kidneys. In this way, I would expect them to work, but _not_ because they overperfuse tissues or cause a cardiac output that would kill you.

Therefore, I hereby dispute the statement "It also increases peripheral vascular resistance, which in turn increases arterial blood pressure." I challenge anyone to produce scientific evidence to support it. It is _not_ common knowledge; it is a common misconception. If you remove that ONE sentence, the remaining paragraph actually describes well enough (for me) how Vasopressin controls [arterial] blood pressure by helping to manage water, salt, and kidney functions.

Please remove that ONE sentence. It is a small (even if some might feel outrageous) request on behalf of scientific rigor and the facts. Having stated a bias here, I should not do it myself. Should I?

--JimRodgers (talk) 03:24, 13 February 2011 (UTC)


 * Per WP:BOLD, you should go ahead and remove the sentence yourself. If someone objects then it should be discussed on this talk page until a consensus is reached. Even better would be to correct the sentence and provide a reliable source to support the correction.  Boghog (talk) 09:10, 13 February 2011 (UTC)

Merger proposal for "Vasopressin receptor antagonist"
I think that the Vasopressin receptor antagonist page should be merged with the full article on AVP. As it stands, the AVP page already includes a section on AVP pharmacology, and the receptor antagonist page is basically a stub article with links to more detailed descriptions of the relevant drugs. If we can reach some kind of consensus, I'd like to carry out the merge in one week's time. Techfiend (talk) 06:10, 2 May 2011 (UTC)

Read, View Sources, View History
For some strange reason, when an IP user sees the 3 options at the top right (next to the search bar) they have to click "View Sources" to edit, because there is no "edit" button. I have confirmed this and took a screenshot: 67.77.174.6 (talk) 07:59, 31 August 2011 (UTC)

VACM-1/Cul5 is NOT a receptor
The name VACM-1, for Vasopressin-Activated Calcium Mobilizing receptor, comes from its first discovery as a protein with a vasopressin-response activity. But it has been revealed as Cullin 5, a scaffold protein for ubiquitin ligase E3. That is not a receptor, even though it may well be a protein necessary for vasopressin response in endothelial cells. It should be removed from the vasopressin receptors table. — Preceding unsigned comment added by Takiar (talk • contribs) 22:22, 9 January 2014 (UTC)

Central nervous system: memory formation
I have tagged as 'dubious' the first para of 'Central nervous system' because it makes a significant assertion that is not supported by any citations - and then tries to hide by saying that it is 'controversial'. This smells of. Whoever put it in needs to fix it or I will delete it by end May. --88.97.11.54 (talk) 12:34, 14 May 2014 (UTC)
 * I have deleted the patently dubious text since it remained uncited and stretched credulity. Other uncited material remains! --88.97.11.54 (talk) 15:54, 5 June 2014 (UTC)
 * It's being sold as a nootropic recently. I recall desmopressin being potentially fatal in this context, with the same claims of miraculous memory enhancement.  Some coverage of this without OR should be possible; I'm not approaching this due to my own non-NPOV concern with the recent pushing of compounds like phenibut as benign miracle drugs when they're either extremely-high-risk (toxic) or extremely-addictive (abuse). Unscrupulous merchants are leveraging the known safety of piracetam and phenylpiracetam (e.g. low toxicity and addictive potential compared to amphetamines, etc.) to peddle anything they can label as natural or new as yet another safe cognitive enhancer. --John Moser (talk) 00:12, 4 August 2016 (UTC)

The Role of Vasopressin in Cardiac Arrest
The subsections numbered 4.2.1 "Vasopressin vs. epinephrine" and 4.2.2 "Vasopressin and epinephrine vs. epinephrine alone", including Table 1 and Table 2, are much too technical and esoteric. They show raw data from clinical trials with various clinical endpoints. It looks like something that was meant for a review article in "Critical Care Medicine". Additionally, the general message is inconclusive on vasopressin's role in this situation. I think the entire paragraphs should be deleted or perhaps summarized in one or two sentences. mattelfesso (talk) 08:11, 3 December 2014 (UTC)


 * Go ahead and be bold! If someone doesn't like it they might change it back, in which case there should be a discussion on how to get this right. JFW &#124; T@lk  12:29, 3 December 2014 (UTC)


 * The only tables I see in this article are in sections 1.4 and 2.1 and have nothing to do with clinical trials. The sourcing in sections 4.2.1 and 4.2.2 are mostly recent WP:MEDRS compliant review articles and the text seems to accurately reflect current knowledge (or lack there of). Perhaps the wording could be simplified, but I see no justification for mass deletion. Boghog (talk) 02:23, 4 August 2016 (UTC)


 * Opps, never mind. I saw a recent edit on this talk page and I assumed it was the last section. I now see the edits in question were made some time ago and appear reasonable. Sorry for the confusion. Boghog (talk) 02:35, 4 August 2016 (UTC)

Appreciated
The content and referencing of this article is notable and admirable. I will be editing for brevity and to simply the contents for readers that may not have the vocabulary of those who contributed to this article. If I have edited incorrectly or have removed some vital piece of information that inadvertently changes the meaning of the content, please revert such edits and let me know so that I don't do it again.
 * Best Regards,
 * Barbara Page

Copyvio concerns
Howdy,

I'm a bit concerned that this page has a lot of copyvio material. A large fraction of the text reads identically to http://reliawire.com/vasopressin/ - this may be them copying wikipedia, but they attribute "Anderson DA (2012) Dorland’s Illustrated Medical Dictionary (32nd ed.) Elsevier. ISBN 978-1-4160-6257-8"

Can someone with access to Dorland's help determine the direction of the copying?

Second, in the section relating to Kidney effects, quite a bit of the wording is identical to several pages in Hayes' Principles and Methods of Toxicology.

Google books link: https://books.google.com/books?id=FChZBAAAQBAJ&lpg=PA1762&ots=ZUWJ3GUYS2&pg=PA1762#v=onepage&f=false

Citation of work: Title	Hayes' Principles and Methods of Toxicology, Sixth Edition Editors	A. Wallace Hayes, Claire L. Kruger:: Edition	6, illustrated, revised Publisher	CRC Press, 2014 ISBN 1842145363, 9781842145364 Page 1762

Example sentence which is nearly identical: "Vasopressin also increases the concentration of calcium in the collecting duct cells, by episodic release from intracellular stores"

I wanted to document a couple of the sources, and solicit feedback about how to proceed - it seems a shame to delete much of the page for copyvio, but I don't have access to the original sources, and do not have the time on hand to rewrite. talk (talk) 00:20, 14 June 2017 (UTC)


 * User:MinutiaeAnalysis talk Suspected copyright violations should be reported to WP: very important. I don't know how, but I think it's called WP:COPYVIO. Jytdog knows how to do it. Regards IiKkEe (talk) 18:07, 13 September 2017 (UTC)

Receptors section
I have spotted a problem with the Receptors section: all references in the section, references 21 - 26 are original research, most are animal studies. I'm not enough of an expert to do this, but IMO this section needs to be converted into a narrative text, with appropriate references from review articles and/or text books. Are all the receptors equally important? IiKkEe (talk) 17:46, 13 September 2017 (UTC)

Role of vasopressin in aggressive behavior and auditory hallucinations of personality-disordered subjects
The role and precise mecanism of vasopressin in aggression and hypothalamic-related dysfunctions should be clarified. See: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/204124 Tkadm30 (talk) 12:55, 3 March 2018 (UTC)

Vasopressin during surgery and anaesthesia
Added this section previously. Updated citations today. A previously inserted image, based on published research, was removed, stating "we don't need figures from research papers". I strongly disagree, the image helps the reader to understand how vasopressin and blood pressure change in parallel during surgery. Please note: self-citation. Link: https://commons.wikimedia.org/wiki/File:Blood_pressure_and_Vasopressin_at_removal_of_ovaries,_Z-scores.jpg Odd Höglund (SLU) (talk) 13:28, 3 February 2019 (UTC)

Refrences, citations for connections between AVP release and temprature - fever
Please kindly check the references for circuitries between AVP and temperature control, and fit it into the article, if appreciated.

The temperature centre at the median preoptic nucleus of the anterior hypothalamus (MnPO) is in overlapping, i.e. close proximity of he osmocentre of he OVLT and der circumventricular organs of 3. Ventricle (Romanowsky 2003, Nakamura2011), both areas have interleukin-6 receptors (Swart 2011), are stimulated by non-osmotic stimuli, i.e. IL-6, In other words: fever due to IL-6 released from monocytes, PMN, or further to that from central cells inside oft he blood-brain-barrier, such pituicytes  will release AVP thru activation of osmocentre from the pituitary, causing hyponatremia due to water reabsorption at the kidney,i.e. dilutuion of plasma, similar to SIADH (Mastorakos 1994), which is different from salt wasting. Acute – not chronic - fever as a course of AVP release is now a well now fact in clinical settings, such as bacterial tuberculosis, or viral SARS, Dengue etc.

INFLAMMATION, CYTOKINES, AND TEMPERATURE REGULATION The organum vasculosum laminae terminalis in immune-to-brain febrigenic signaling: a reappraisal of lesion experiments Andrej A. Romanovsky , Naotoshi Sugimoto , Christopher T. Simons , and William S. Hunter 01 AUG 2003https://doi.org/10.1152/ajpregu.00757.2002

EXPERIMENTAL BIOLOGY 2010 | New Investigator Award of the Neural Control and Autonomic Regulation (NCAR) Section, 2010New Investigator Award of the Neural Control and Autonomic Regulation (NCAR) Section, 2010 Central circuitries for body temperature regulation and fever Kazuhiro Nakamura 01 NOV 2011https://doi.org/10.1152/ajpregu.00109.2011

Nephron Physiol •	•	•	. 2011;118(2):45-51. doi: 10.1159/000322238. Epub 2010 Dec 22. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation Reinout M Swart 1, Ewout J Hoorn, Michiel G Betjes, Robert Zietse Affiliations expand •	PMID: 21196778 •	DOI: 10.1159/000322238

J Clin Endocrinol Metab •	•	•	. 1994 Oct;79(4):934-9. doi: 10.1210/jcem.79.4.7962300. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion G Mastorakos 1, J S Weber, M A Magiakou, H Gunn, G P Chrousos Affiliations expand •	PMID: 7962300 •	DOI: 10.1210/jcem.79.4.7962300Robertley1 (talk) 10:22, 24 August 2020 (UTC)

carbamazepine- chlorpropamide: antidiuretic effect
please correct the article, the diuretic statement is wrong

The statement within the article on diuresis is wrong. Carbamezepin, chlorpropamide are anitidiurectic, releasing ADH from pitiuitary

Acta Endocrinol (Copenh)

•	. 1981 Feb;96(2):145-53. doi: 10.1530/acta.0.0960145. Essential hypernatraemia, antidiuretic hormone and neurophysin secretion: response to chlorpropamide T W AvRuskin, S C Tang, C Juan •	PMID: 7468100 •	DOI: 10.1530/acta.0.0960145

Case Reports Tohoku J Exp Med •	•	•	. 1979 Feb;127(2):101-11. doi: 10.1620/tjem.127.101. Hypothalamic hypernatremia due to volume--dependent ADH release, and its treatment with carbamazepine and clofibrate T Kimura, K Matsui, K Ota, K Yoshinaga •	PMID: 760257 •	DOI: 10.1620/tjem.127.101Robertley1 (talk) 11:55, 24 August 2020 (UTC)

Chemical structures seem to be wrong
They contain 10 amino acids and not only 9, as written several times in the text. 141.63.224.168 (talk) 15:53, 16 August 2023 (UTC)